Skip to main content
SpringerLink
Log in

Long-term prognosis of rituximab-induced hypogammaglobulinemia in children with complicated steroid-dependent nephrotic syndrome: impact of multiple rituximab courses

  • Letter to the Editors
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Inoki Y, Nishi K, Sato M, Ogura M, Kamei K (2022) The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome. Pediatr Nephrol. https://doi.org/10.1007/s00467-022-05652-9

    Article  Google Scholar 

  2. Inoki Y, Kamei K, Nishi K, Sato M, Ogura M, Ishiguro A (2022) Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome. Pediatr Nephrol 37:1057–1066

    Article  Google Scholar 

  3. Fujinaga S, Tomii Y (2020) Profound effect of post-rituximab mycophenolate mofetil administration for persistent hypogammaglobulinemia in young children with steroid-dependent nephrotic syndrome. Clin Exp Nephrol 24:386–387

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Maruzen-Yushodo Co., Ltd., for the English language editing.

Funding

SF has received Grants-in-Aid for research of Saitama Children’s Medical Center (2021-B-3).

Author information

Authors and Affiliations

  1. Division of Nephrology, Saitama Children’s Medical Center, 1-2 Shintoshin, Chuo-ku, Saitama, Saitama, 330-8777, Japan

    Yuta Onuki & Shuichiro Fujinaga

  2. Children’s Medical Center, Showa University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan

    Yuta Onuki

Authors
  1. Yuta Onuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuichiro Fujinaga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shuichiro Fujinaga.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Research Committee and/or National Research Committee at which the study was conducted with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The ethics committee of Saitama Children’s Medical Center approved this study (approval number 2021–05-012).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Onuki, Y., Fujinaga, S. Long-term prognosis of rituximab-induced hypogammaglobulinemia in children with complicated steroid-dependent nephrotic syndrome: impact of multiple rituximab courses. Pediatr Nephrol 38, 615–616 (2023). https://doi.org/10.1007/s00467-022-05741-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-022-05741-9

Search

Navigation